Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,114,707
-$281,268 QoQ
Shares Held
82,327
-64.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#144
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $248,035,659 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
346,193 | $44,485,800 | |
| 2 | AMGN |
Amgen Inc
|
97,240 | $35,212,548 | |
| 3 | JNJ |
Johnson & Johnson
|
137,584 | $34,942,208 | |
| 4 | LLY |
ELI LILLY & Co
|
22,773 | $27,314,621 | |
| 5 | ABBV |
AbbVie Inc.
|
87,496 | $22,017,493 | |
| 6 | PFE |
Pfizer Inc
|
873,428 | $21,032,146 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
302,317 | $17,419,505 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,450 | $16,102,033 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,114,707 | 82,327 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,395,975 | 233,051 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,785,681 | 388,519 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $5,551,421 | 519,796 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,998,734 | 619,704 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,189,658 | 684,329 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,539,920 | 706,429 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $12,636,589 | 660,564 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $13,266,754 | 640,906 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $11,535,905 | 613,612 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,843,398 | 543,925 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,923,364 | 456,415 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,232,765 | 347,562 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,688,100 | 241,841 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,080,209 | 146,087 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,475,861 | 63,071 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $530,415 | 15,716 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $982,441 | 28,126 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,245,800 | 40,913 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,598,053 | 48,736 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,549,523 | 51,207 | Shares | Sole | 2021-07-30 | |
| No filing history on record for this holder in this stock. | ||||||